Navigation Links
Momentum of Stem cell research impeded by legal challenges

California in the year 2005 planned to begin stem cell research in the state with the approval of 61% of voters passing the Proposition 71. But the legal challenges have impeded the initiative. //

The officials now say that it would take spring 2007 before the project will be initiated. Zach Hall, president of the California Institute for Regenerative Medicine, told his board of directors that it would commence the project as soon as possible.

The lawsuit has prevented the agency from borrowing $3 billion which will be used by the agency for issuing as research grants over the next 10 years.

But the institute is bestowed with $50 million in temporary private funds from philanthropies and wealthy individuals to start training stem cell researchers.

Zach Hall also suggested another $2 million for collaborating with other scientific organizations, including international meetings and conferences.

So far this project is been fueled by a $3 million state loan and a $5 million philanthropic gift, but that money is set to run out in June.

The professor said that Universities and other Research institutions have to rely on their own funding sources to begin their stem cell research programs.

Robert Birgeneau, an institute board member and chancellor of University of California Berkeley, said his campus could significantly expand research programs if the initial funds were released by the government.

Stem cell research is a controversial topic to discuss because it involves the destruction of many embryos. But it is believed that this research could yield treatments for diseases like Parkinson's, Alzheimer's and insulin-dependent diabetes.

The lawsuit alleges that the managers of the stem cell agency are not state officials and many of them have conflicts of interest.

The judge though declined to throw out the suits, ruled out all the challenges that have blocked the progress of the research as unconstitutional.


'"/>




Related medicine news :

1. Global Momentum for Smoke-Free Indoor Environments at Tipping Point
2. Stem cell research- now Nobel Laureates join the debate
3. Spouses and other partners lower blood pressure says new research
4. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
5. Stem cell research
6. Gene researchers make Malaria-resistant mosquito
7. Novel research on liver cancer
8. Space research leads to needle-free blood tests
9. SARS research confirms link to animals
10. New turn in stem cell research
11. Calcium Supplementation May Not Actually Prevent colon cancer say researchers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: